01 / Technology & operations
How to evaluate robotic sample preparation, autonomous laboratories, AI validation and LIMS integration: evidence boundaries, pilots and vendor due diligence.
Primary references · Checked November 7, 2026
02 / Capital & ownership
Laboratory acquisition due diligence: transaction stages, strategic versus financial ownership, accreditation scope and integration questions with a historical Element–Temasek example.
Primary references · Checked November 7, 2026
03 / Capacity & institutions
Evaluate laboratory construction from proposal to operation: funding stages, design basis, commissioning, service capacity and relocation risk without invented pipeline totals.
Primary references · Checked November 7, 2026
04 / Risk & governance
Read laboratory Chapter 11, complaints, settlements, CLIA oversight and restructuring with exact entity, dates and legal posture; no inference of guilt or solvency from a single record.
Primary references · Checked November 7, 2026
05 / Technology & operations
Scientist-to-CEO operating methods for independent and captive laboratories: service-level costs, contribution, pricing, client concentration and hire/automate/outsource decisions; no invented benchmarks.
Primary references · Checked November 7, 2026
06 / Risk & governance
Accreditation scope, ISO/IEC 17025, CLIA distinctions and standards economics: verify site and activities, avoid blanket quality claims and keep business guidance separate from method tools.
Primary references · Checked November 7, 2026
07 / Capacity & institutions
Federal, state, university, nonprofit and public laboratories: distinguish proposed funding, appropriations, obligations, contracts, shared cores and facility milestones.
Primary references · Checked November 7, 2026
08 / Markets & geography
Cross-border laboratory due diligence across China, India, Europe and Southeast Asia: recognition, scope, market-access evidence and ownership without country-based quality assumptions.
Primary references · Checked November 7, 2026
09 / Technology & operations
A laboratory workforce research method for checking 11 or more distinct employer openings: deduplication, evidence dates, role scope and the difference between vacancies and hires.
Primary references · Checked November 7, 2026
10 / Risk & governance
How to distinguish CLIA certificate action, state licensing, FDA diagnostic recalls and historical enforcement data: source hierarchy, exact sites, affected lots and decision dates.
Primary references · Checked November 7, 2026
11 / Capital & ownership
Laboratory investor research from entity and ownership evidence to service mix, deal perimeter, earnings comparability and integration risk, with a dated Labcorp–Invitae asset-purchase example.
Primary references · Checked November 7, 2026